Literature DB >> 12799521

Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives.

J Timár1, S Gyarmati, A Szabó, S Fürst.   

Abstract

Repeated administration of amphetamine derivatives is reported to induce neurotoxicity in rat brain. Methamphetamine (MA) impairs the function of both the dopaminergic and serotonergic systems, 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) affects primarily the latter system. The neurochemical deficits induced by these amphetamines have been described in detail, but relatively few data have been reported regarding the behavioural consequences of the neurotoxic treatment. The aim of the present study was to investigate short- and long-term behavioural consequences of treatment with neurotoxic doses of (+)MA or (+)MDMA. Spontaneous locomotor activity in novel surroundings and cognitive function (avoidance behaviour) were evaluated. Rats were treated with four s.c. injections of 10 mg/kg (+)MA or (+)MDMA with a 2-hour interval between each injection. Behavioural tests were then carried out 3 days, 1, 2 and 4 weeks after these treatments. A reduction of spontaneous locomotor activity in novel surroundings was detected 3 days after the treatment with the study drugs, but not after 1, 2 and 4 weeks. No change in passive and active avoidance learning was observed. The lack of marked behavioural changes after a neurotoxic dose regimen indicates that some compensatory mechanisms may develop and counterbalance the neurochemical changes induced by these amphetamine compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799521     DOI: 10.1097/00008877-200305000-00003

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  10 in total

1.  Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.

Authors:  Kevin Sean Murnane; Shane Alan Perrine; Brendan James Finton; Matthew Peter Galloway; Leonard Lee Howell; William Edward Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2011-10-13       Impact factor: 4.530

2.  3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

Authors:  Jessica A Able; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

3.  Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose.

Authors:  Madeline M Pantoni; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

4.  Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice.

Authors:  Azizi Ray; Neha Milind Chitre; Cedrick Maceo Daphney; Bruce E Blough; Clinton E Canal; Kevin Sean Murnane
Journal:  Psychopharmacology (Berl)       Date:  2018-10-01       Impact factor: 4.530

Review 5.  Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

6.  Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.

Authors:  Lucina E Lizarraga; Andy V Phan; Aram B Cholanians; Joseph M Herndon; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2014-03-04       Impact factor: 4.849

7.  Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats.

Authors:  Ilsun M White; Takehiro Minamoto; Joseph R Odell; Joseph Mayhorn; Wesley White
Journal:  Brain Res       Date:  2009-02-24       Impact factor: 3.252

8.  Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.

Authors:  Irina N Krasnova; Amber B Hodges; Bruce Ladenheim; Raina Rhoades; Crystal G Phillip; Angela Cesena; Ekaterina Ivanova; Christine F Hohmann; Jean Lud Cadet
Journal:  Neurosci Res       Date:  2009-06-24       Impact factor: 3.304

Review 9.  Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.

Authors:  Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

10.  The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration.

Authors:  Grego David Apóstol Del Rosal; Ilhuicamina Daniel Limón; Isabel Martínez; Aleidy Patricio-Martínez
Journal:  Neurotox Res       Date:  2021-07-19       Impact factor: 3.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.